Reduced glutathione in amyotrophic lateral sclerosis: An open, crossover, randomized trial

Neurological Sciences

Volumn 19, Issue 6, 1998, Pages 363-366

  Chio, A ^a   Cucatto, A ^a   Terreni, A A ^a   Schiffer, D ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Amyotrophic lateral sclerosis; Free radicals; Reduced glutathione; Therapeutic trial

Indexed keywords

GLUTATHIONE;

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE COURSE; HUMAN; MIDDLE AGED; PATHOPHYSIOLOGY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

AMYOTROPHIC LATERAL SCLEROSIS; CROSS-OVER STUDIES; DISEASE PROGRESSION; GLUTATHIONE; HUMANS; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0032227330     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, Hentati A, Donaldson D, Goto J, O'Regan JP, Deng HX (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 362(6415):59-62
2. Smith RG, Appel SH (1995) Molecular approaches to amyotrophic lateral sclerosis. Annu Rev Med 46:133-145
3. Rothstein JD, Kuncl RW (1995) Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 65:643-651
4. Sardesai VM (1995) Role of antioxidant in health maintenance. Nutr Clin Pract 10:19-25
5. Bains JS, Shaw CA (1997) Neurodegenerative disorders in humans: The role of glutathione in oxidative stress-mediated neuronal death. Brain Res Brain Res Rev 25:335-358
6. Mitchell JD, Jackson MJ (1992) Free radicals, amyotrophic lateral sclerosis, and neurodegenerative disease. In: Smith RA (ed) Handbook of amyotrophic lateral sclerosis. Marcel Dekker, New York, pp 533-54
7. Moumen R, Nouvelot A, Duval D, Lachevalier B, Viader F (1997) Plasma superoxide dismutase and glutathione peroxidase activity in sporadic amyotrophic lateral sclerosis. J Neurol Sci 151:35-39
8. World Federation of Neurology Research Group on Neuromuscular Diseases and Subcommittee on Motor Neuron Disease/Amyotrophic Lateral Sclerosis (1994) El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 124 [Suppl]:96-107
9. The Italian ALS Study Group (1993) Branched-chain amino acids and amyotrophic lateral sclerosis: A treatment failure? Neurology 43:2466-2470
10. Daniel WW (1978) Biostatistics: A foundation for analysis in the health sciences, 2nd edn. John Wiley & Sons, New York
11. CPMP Working Party on Efficacy of Medical Products (1990) EEC note for guidance: Good clinical practice for trials on medical products in the European Community. Pharm Toxicol 67:361-372
12. Swash M, Schwartz MS (1992) What do we really known about amyotrophic lateral sclerosis? J Neurol Sci 113:4-16
13. Kannan R, Kuhlenkamp JF et al (1990) Evidence for carrier-mediated transport of glutathione across blood-brain barrier in the rat. J Clin Invest 85:2009-2013
14. Lanius RA, Krieger C, Wagey R, Shaw CA (1993) Increased [35S]glutathione binding sites in spinal cord from patients with sporadic amyotrophic lateral sclerosis. Neurosci Lett 163:89-92